1. "Regional Cell Preparation Center", an industrialized development model of individualized cell therapy technology explored by Beijing Biological University, won the title of "Demonstration Project of Regional Agglomeration of Strategic Emerging Industries" by the National Development and Reform Commission. The infrastructure of cell therapy industrialization-"comprehensive cell bank+regional cell preparation center" has been laid out in South China, East China, Southwest China and Northwest China. This is based on the characteristics of individualization and instability of cell therapy technology. It "paved" a "cell therapy highway network" that can meet the clinical needs in time and take into account the production scale, connecting clinical demanders and advanced technology suppliers, and constructing a standardized cell storage and preparation model that meets international standards and development trends. The Code for the Construction and Management of Cell Preparation Center, jointly drafted by Shenzhen Municipal Market Supervision Administration, Shenzhen Development and Reform Commission, Shenzhen Beike Biotechnology Co., Ltd. and shenzhen institute of standards and technology, was officially released in June, 20 16. Code for Construction and Management of Comprehensive Cell Bank (No.:SZDB/Z266-20 17) was officially released on September 20 17. It provides a useful reference for the formulation of the industry standard of cell therapy technology in China. The implementation of a series of norms will surely lead and accelerate the cell therapy industry into the process of legalization, standardization and specialization. Based on "comprehensive cell bank+regional cell preparation center", with the help of "internet plus" and the cooperation of industrial investment funds, Beike Bio will form a nationwide personalized cell therapy industry public service platform and personalized cell therapy technology network.
2. Beike Bio has the first batch of certified professionals in the industry-cell preparation engineers and cell quality management engineers, and took the lead in introducing the third-party professional cell quality testing platform-Shenzhen Kono Medical Laboratory, which is the first cell quality testing platform in China to ensure cell quality and engage in pathogen screening and cell verification. Shenzhen comprehensive cell bank is approved by Shenzhen Development and Reform Commission according to Shenzhen Life and Health Industry Development Plan (20 13-2020), and "Shenzhen Beike Biotechnology Co., Ltd. prepares to build Shenzhen comprehensive cell bank" (deep development reform [2065438+04]171. In order to face the problems of different quality standards and disjointed information in the current cell industry, Shenzhen Comprehensive Cell Bank undertakes the responsibility of establishing key technologies such as third-party certification and quality control, promoting the formulation of cell industry standards and forming a traceable standardized information management system platform, and providing technical services for Shenzhen's life and health industry.